TBZNSETRIB BHIMJI ZAVERI LTD· Consumer DurablesHighNeutral
Announced Tue, 27 Oct, 2026 · 16:40 IST

TBZ Q2 PAT falls 49.7% as margins shrink; GRT acquisition advances

Ebitda Margin CompressionNegative Operating CashflowResults View source PDFExplain this filing

TBZ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.4%Reaction day
₹677.70
prior close
₹641.35
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-5.4% vs market
Gems Jewellery And Watches peers, median of 29sector-0.1%-5.3% vs sector

On the reaction day the stock moved 5.4 pts less than Nifty Microcap 250 and 5.3 pts less than its Gems Jewellery And Watches peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.4+0.1-5.4-0.1-5.3
Next day
-5.9+0.7-6.7+0.4-6.4
2d
-10.3pendingpending-3.3-7.1
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Gems Jewellery And Watches peers, median of 29Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone Q2 revenue was Rs 7,053.53 million, up 2.5% year on year, but PAT fell 49.7% to Rs 154.30 million as gross margin dropped to 14.2% from 16.9%. H1 revenue rose 17.9% to Rs 15,463.27 million and EBITDA rose 3.1%, while PAT slipped 6.5%. Operating cash flow was negative. GRT's proposed 74.12% purchase received approval from India's competition regulator; a public shareholder offer for 25.88% at Rs 249.61 per share is still conditional.

Likely market impact

Lower margins and negative operating cash flow are concerns, but H1 growth and the GRT deal may support the stock. Completion needs approvals.